Saturday 31 October 2026
Export SBRA’s income statement to Excel — free account
Sabra Healthcare REIT, Inc.
SBRA Real Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024. In the quarter to June 2026, revenue grew 24.7%, EPS fell 135.7%, free cash flow fell 666.1% and total debt rose 5.91%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three.
19.74
0.13
+0.66%
Follow SBRA
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
26.76 | 13.70 | 10.84 | 62.76 | 25.93 | 0.00 | 0.00 | 283.80 | 32.07 | 29.14 |
Piotroski F-Score |
5 | 4 | 6 | 5 | 4 | 3 | 4 | 6 | 6 | 5 |
P/S ratio |
6.17 | 4.94 | 4.71 | 6.04 | 5.98 | 5.21 | 4.66 | 5.07 | 5.75 | 5.90 |
P/FCF ratio |
13.47 | 0.00 | 6.47 | 6.39 | 15.49 | 9.42 | 11.36 | 8.53 | 18.78 | 0.00 |
P/Operating CF |
38.17 | 24.43 | 37.89 | 41.83 | 40.07 | 30.29 | 43.09 | 41.67 | 50.57 | 52.28 |
P/B ratio |
1.58 | 0.59 | 0.90 | 1.15 | 1.05 | 0.88 | 0.95 | 1.17 | 1.48 | 1.62 |
Price to Tangible BV |
1.62 | 0.62 | 0.94 | 1.18 | 1.08 | 0.89 | 0.97 | 1.18 | 1.49 | 1.66 |
EV/Sales |
10.68 | 11.81 | 9.80 | 9.59 | 9.84 | 9.21 | 8.59 | 8.72 | 9.09 | 9.06 |
EV/EBITDA |
13.87 | 15.59 | 12.31 | 15.90 | 13.75 | 13.79 | 16.34 | 14.47 | 15.67 | 15.83 |
EV/Operating CF |
15.82 | 35.52 | 16.95 | 17.04 | 16.60 | 14.72 | 16.99 | 18.79 | 20.59 | 20.14 |
EV/FCF |
23.32 | (34.25) | 13.46 | 10.16 | 25.46 | 16.65 | 20.93 | 14.68 | 29.69 | (122.74) |
Quick Ratio |
0.87 | 5.73 | 0.63 | 0.45 | 0.45 | 0.81 | 0.38 | 0.34 | 0.56 | 0.65 |
Current Ratio |
3.30 | 6.85 | 1.83 | 1.44 | 1.15 | 3.60 | 3.27 | 3.41 | 4.32 | 4.29 |
Net Debt/EBITDA |
5.86 | 9.07 | 6.39 | 5.89 | 5.38 | 5.99 | 7.47 | 6.07 | 5.76 | 5.53 |
Debt/Assets |
53.43% | 48.27% | 48.49% | 39.58% | 39.63% | 40.13% | 43.61% | 44.82% | 45.58% | 46.04% |
Debt/Equity |
1.19 | 0.99 | 0.99 | 0.69 | 0.70 | 0.71 | 0.82 | 0.86 | 0.88 | 0.90 |
Asset Turnover |
0.11 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | 0.11 | 0.12 | 0.13 | 0.14 |
Operating CF/Net income |
2.93 | 0.92 | 1.34 | 5.40 | 2.56 | (3.15) | (4.07) | 21.85 | 2.45 | 2.24 |
Capex/Depreciation |
(0.83) | (2.43) | 0.49 | 1.39 | (0.70) | (0.23) | (0.32) | 0.46 | (0.56) | (2.17) |
Interest Coverage |
2.04 | 2.21 | 2.07 | 1.72 | 2.51 | 2.04 | 1.33 | 1.83 | 2.07 | 2.28 |
| 5.80% | 6.65% | 8.05% | 2.05% | 4.01% | (3.34%) | (2.41%) | 0.47% | 4.57% | 5.59% | |
| 2.54% | 3.19% | 3.93% | 1.08% | 2.30% | (1.90%) | (1.32%) | 0.25% | 2.37% | 2.88% | |
ROIC |
3.77% | 1.96% | 2.97% | 2.33% | 2.75% | 2.22% | 1.60% | 2.50% | 2.93% | 3.04% |
Return on Tangible Assets |
2.86% | 2.25% | 4.54% | 1.28% | 2.61% | (2.05%) | (1.47%) | 0.28% | 2.58% | 3.06% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
6.78% | 7.94% | 5.95% | 4.67% | 5.47% | 6.09% | 6.33% | 7.33% | 7.12% | 6.93% |
Intangible Assets out of Total Assets |
0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
2.88% | 2.05% | 1.23% | 1.48% | 1.32% | 1.39% | 1.19% | 1.22% | 1.28% | 1.47% |
Graham Net Nets |
(0.70) | (1.43) | (1.10) | (0.61) | (0.67) | (0.70) | (0.76) | (0.65) | (0.51) | (0.47) |
Graham Number |
17.94 | 31.95 | 24.99 | 11.94 | 15.79 | 0.00 | 0.00 | 3.69 | 11.94 | 13.08 |
Earnings Yield |
3.74% | 7.30% | 9.22% | 1.59% | 3.86% | (3.77%) | (2.70%) | 0.35% | 3.12% | 3.43% |
Free Cash Flow Yield |
7.43% | (6.98%) | 15.45% | 15.65% | 6.46% | 10.62% | 8.80% | 11.73% | 5.33% | (1.25%) |
Revenue per Share |
3.99 | 3.87 | 3.50 | 3.54 | 2.90 | 2.60 | 2.71 | 2.80 | 3.01 | 3.21 |
Operating CF per Share |
2.69 | 1.29 | 2.02 | 1.99 | 1.72 | 1.63 | 1.37 | 1.30 | 1.33 | 1.44 |
Capex per Share |
(0.87) | (2.62) | 0.52 | 1.35 | (0.60) | (0.19) | (0.26) | 0.36 | (0.41) | (1.68) |
Free Cash Flow per Share |
1.83 | (1.33) | 2.55 | 3.34 | 1.12 | 1.44 | 1.11 | 1.66 | 0.92 | (0.24) |
Cash per Share |
0.53 | 5.56 | 0.33 | 0.26 | 0.32 | 0.53 | 0.23 | 0.20 | 0.28 | 0.32 |
Shareholders Equity per Share |
15.56 | 32.54 | 18.25 | 18.64 | 16.53 | 15.43 | 13.23 | 12.12 | 11.74 | 11.70 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
15.56 | 32.54 | 18.25 | 18.64 | 16.53 | 15.43 | 13.23 | 12.12 | 11.74 | 11.70 |
Free Cash Flow |
119.35 | (140.83) | 453.94 | 624.94 | 231.30 | 315.01 | 256.36 | 384.81 | 215.40 | (57.20) |
Working Capital |
91.06 | 599.32 | 78.55 | 47.73 | 22.09 | 371.98 | 323.07 | 330.36 | 391.03 | 392.91 |
Capital Expenditures |
(56.58) | (276.62) | 93.35 | 252.46 | (123.55) | (41.38) | (59.37) | 84.24 | (95.14) | (405.82) |
Net Current Asset Value |
(1,119.61) | (2,893.19) | (3,237.18) | (2,424.32) | (2,408.01) | (2,072.20) | (2,225.95) | (2,116.27) | (2,053.47) | (2,157.37) |
EV/EBIT |
21.07 | 24.68 | 20.04 | 29.15 | 23.40 | 26.06 | 38.14 | 27.26 | 26.81 | 27.37 |
Capex to Sales |
0.22 | 0.68 | (0.15) | (0.38) | 0.21 | 0.07 | 0.10 | (0.13) | 0.14 | 0.52 |
Price to Operating Income |
12.16 | 10.32 | 9.64 | 18.34 | 14.23 | 14.74 | 20.70 | 15.83 | 16.95 | 17.82 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 |
Cash ROIC |
5.28% | (1.90%) | 6.93% | 10.52% | 3.96% | 5.35% | 4.56% | 7.31% | 4.12% | (1.05%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
37.41 | 71.08 | 98.68 | 101.81 | 127.53 | 144.63 | 142.62 | 139.62 | 127.44 | 118.61 |
Average Assets |
2,367.38 | 4,649.10 | 6,848.79 | 6,367.30 | 6,027.45 | 5,976.16 | 5,857.19 | 5,566.91 | 5,344.91 | 5,398.54 |
Average Common Equity |
1,034.68 | 2,226.37 | 3,345.97 | 3,371.60 | 3,448.84 | 3,394.38 | 3,217.96 | 2,929.46 | 2,771.91 | 2,782.54 |
Columns are period end dates